These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

941 related articles for article (PubMed ID: 15266473)

  • 41. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.
    Squizzato A; Keller T; Romualdi E; Middeldorp S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD005158. PubMed ID: 21249668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ticlopidine versus oral anticoagulation for coronary stenting.
    Cosmi B; Rubboli A; Castelvetri C; Milandri M
    Cochrane Database Syst Rev; 2001; 2001(4):CD002133. PubMed ID: 11687144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R; Pearce LA
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clopidogrel hydrogen sulphate for atrial fibrillation.
    Garg N; Rajpurohit N; Flaker G
    Expert Opin Pharmacother; 2011 Aug; 12(11):1781-7. PubMed ID: 21663525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.
    Malloy RJ; Kanaan AO; Silva MA; Donovan JL
    Clin Ther; 2013 Oct; 35(10):1490-1500.e7. PubMed ID: 24139421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Preventing cerebrovascular accidents during atrial fibrillation].
    Ederhy S; Meuleman C; Hammoudi N; Janower S; Boccara F; Cohen A
    Presse Med; 2005 Oct; 34(18):1315-24. PubMed ID: 16269996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
    Valentine N; Van de Laar FA; van Driel ML
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD005449. PubMed ID: 23152231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
    Steinhubl S; Berger P
    Am Heart J; 2003 Jun; 145(6):971-8. PubMed ID: 12796751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of antiplatelet drugs in the prevention of cardiovascular events.
    Tendera M; Wojakowski W
    Thromb Res; 2003 Jun; 110(5-6):355-9. PubMed ID: 14592562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; De Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001342. PubMed ID: 16855967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
    Saxena R; Koudstaal P
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin.
    De Schryver EL; Algra A; Kappelle LJ; van Gijn J; Koudstaal PJ
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD001342. PubMed ID: 22972051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of warfarin and aspirin in secondary prevention of stroke.
    Elkind MS
    Curr Cardiol Rep; 2004 Mar; 6(2):135-42. PubMed ID: 14759359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial.
    Schwalm JD; Ahmad M; Salehian O; Eikelboom JW; Natarajan MK
    J Thromb Thrombolysis; 2010 Aug; 30(2):127-32. PubMed ID: 20157843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
    Allemang MT; Rajani RR; Nelson PR; Hingorani A; Kashyap VS
    Ann Vasc Surg; 2013 Jan; 27(1):62-7. PubMed ID: 22981017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR; Yusuf S;
    Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary prevention of ischaemic cardiovascular disorders with antiplatelet agents.
    Meade T
    Handb Exp Pharmacol; 2012; (210):565-605. PubMed ID: 22918747
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.